SCHEMBL8257993

SCHEMBL8257993

N[C@H]1CC[C@H](OC(=O)CCC(=O)O)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
NAAA Q02083 2/20 0.41
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SMYD3 Q9H7B4 1/20 0.37
EGLN1 Q9GZT9 2/20 0.36
KDM6B O15054 1/20 0.36
KDM5C P41229 1/20 0.36
PHF8 Q9UPP1 1/20 0.36
KDM2A Q9Y2K7 1/20 0.36
ALKBH5 Q6P6C2 1/20 0.36
SUCNR1 Q9BXA5 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.34
MMP3 P08254 1/20 0.34
CYP2C19 P33261 1/20 0.33
F2 P00734 1/20 0.33
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19690549 0.92 LMNA (0.47) LMNANAAAGAAMAPTALDH1A1
SCHEMBL5071456 0.92 LMNA (0.47) LMNANAAAGAAMAPTALDH1A1
Butane SCHEMBL2855752 0.84 NAAA (0.53) LMNANAAAGAAMAPTALDH1A1
SCHEMBL2818269 0.84 LMNA (0.42) LMNANAAAGAAMAPTALDH1A1
SCHEMBL3473161 0.83 NAAA (0.56) LMNANAAAALDH1A1EGLN1KDM6B
SCHEMBL27617118 0.83 NAAA (0.52) LMNANAAAGAAMAPTALDH1A1
SCHEMBL19690548 0.82 NAAA (0.52) NAAAGAAMAPTALDH1A1SMN1; SMN2
SCHEMBL6864567 0.82 LMNA (0.41) LMNANAAAGAAMAPTALDH1A1
SCHEMBL22213807 0.82 NAAA (0.58) LMNANAAAALDH1A1SMN1; SMN2MMP3
Methane SCHEMBL9340161 0.82 NAAA (0.55) NAAAGAAMAPTALDH1A1SMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289893-A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith Signal Pharmaceuticals LLC (US) 2011-03-02 EP disclosed
EP-2112151-A2 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith Signal Pharmaceuticals LLC (US) 2009-10-28 EP disclosed
EP-1838710-B1 HALOARYL SUBSTITUTED AMINOPURINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARM LLC (US) 2009-07-01 EP disclosed
WO-2006076595-A1 HALOARYL SUBSTITUTED AMINOPURINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2006-07-20 WO disclosed